183 related articles for article (PubMed ID: 25744824)
1. A red-shifted photochromic sulfonylurea for the remote control of pancreatic beta cell function.
Broichhagen J; Frank JA; Johnston NR; Mitchell RK; Šmid K; Marchetti P; Bugliani M; Rutter GA; Trauner D; Hodson DJ
Chem Commun (Camb); 2015 Apr; 51(27):6018-21. PubMed ID: 25744824
[TBL] [Abstract][Full Text] [Related]
2. Optical control of insulin release using a photoswitchable sulfonylurea.
Broichhagen J; Schönberger M; Cork SC; Frank JA; Marchetti P; Bugliani M; Shapiro AM; Trapp S; Rutter GA; Hodson DJ; Trauner D
Nat Commun; 2014 Oct; 5():5116. PubMed ID: 25311795
[TBL] [Abstract][Full Text] [Related]
3. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
[TBL] [Abstract][Full Text] [Related]
4. Insulin stimulus-secretion coupling is triggered by a novel thiazolidinedione/sulfonylurea hybrid in rat pancreatic islets.
Mendes CP; Postal BG; Oliveira GTC; Castro AJG; Frederico MJS; Moraes ALL; Neuenfeldt PD; Nunes RJ; Menegaz D; Silva FRMB
J Cell Physiol; 2018 Jan; 234(1):509-520. PubMed ID: 29968920
[TBL] [Abstract][Full Text] [Related]
5. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
[TBL] [Abstract][Full Text] [Related]
6. A High-Throughput Assay for the Pancreatic Islet Beta-Cell Potassium Channel: Use in the Pharmacological Characterization of Insulin Secretagogues Identified from Phenotypic Screening.
Song L; Barrett DG; Cox KL; Efanov AM; Syed SK; Tomandl D; Willard FS
Assay Drug Dev Technol; 2021 Jan; 19(1):27-37. PubMed ID: 33164547
[TBL] [Abstract][Full Text] [Related]
7. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs.
Zhang CL; Katoh M; Shibasaki T; Minami K; Sunaga Y; Takahashi H; Yokoi N; Iwasaki M; Miki T; Seino S
Science; 2009 Jul; 325(5940):607-10. PubMed ID: 19644119
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic and extrapancreatic sulfonylurea receptors.
Panten U; Schwanstecher M; Schwanstecher C
Horm Metab Res; 1992 Dec; 24(12):549-54. PubMed ID: 1478610
[TBL] [Abstract][Full Text] [Related]
9. Cooperation between cAMP signalling and sulfonylurea in insulin secretion.
Shibasaki T; Takahashi T; Takahashi H; Seino S
Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():118-25. PubMed ID: 25200305
[TBL] [Abstract][Full Text] [Related]
10. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
Remedi MS; Nichols CG
PLoS Med; 2008 Oct; 5(10):e206. PubMed ID: 18959471
[TBL] [Abstract][Full Text] [Related]
11. Exchange protein directly activated by cyclic AMP isoform 2 is not a direct target of sulfonylurea drugs.
Tsalkova T; Gribenko AV; Cheng X
Assay Drug Dev Technol; 2011 Feb; 9(1):88-91. PubMed ID: 21133673
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of sulfonylurea stimulation of insulin release.
Hellman B
Acta Biol Med Ger; 1982; 41(12):1211-9. PubMed ID: 6765162
[TBL] [Abstract][Full Text] [Related]
13. Both triggering and amplifying pathways contribute to fuel-induced insulin secretion in the absence of sulfonylurea receptor-1 in pancreatic beta-cells.
Nenquin M; Szollosi A; Aguilar-Bryan L; Bryan J; Henquin JC
J Biol Chem; 2004 Jul; 279(31):32316-24. PubMed ID: 15175349
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells.
Miura A; Yamagata K; Kakei M; Hatakeyama H; Takahashi N; Fukui K; Nammo T; Yoneda K; Inoue Y; Sladek FM; Magnuson MA; Kasai H; Miyagawa J; Gonzalez FJ; Shimomura I
J Biol Chem; 2006 Feb; 281(8):5246-57. PubMed ID: 16377800
[TBL] [Abstract][Full Text] [Related]
15. A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agen.
Sugawara K; Honda K; Reien Y; Yokoi N; Seki C; Takahashi H; Minami K; Mori I; Matsumoto A; Nakaya H; Seino S
PLoS One; 2016; 11(10):e0164785. PubMed ID: 27764176
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of insulin secretion and its modulation by sulfonylureas.
Panten U
Contrib Nephrol; 1989; 73():16-21; discussion 22-3. PubMed ID: 2689091
[No Abstract] [Full Text] [Related]
17. The stimulus-secretion coupling of glucose-induced insulin release. XII. Effects of diazoxide and gliclazide upon 45 calcium efflux from perifused islets.
Malaisse WJ; Pipeleers DG; Mahy M
Diabetologia; 1973 Feb; 9(1):1-5. PubMed ID: 4573675
[No Abstract] [Full Text] [Related]
18. β-Cell-intrinsic β-arrestin 1 signaling enhances sulfonylurea-induced insulin secretion.
Barella LF; Rossi M; Zhu L; Cui Y; Mei FC; Cheng X; Chen W; Gurevich VV; Wess J
J Clin Invest; 2019 Jun; 129(9):3732-3737. PubMed ID: 31184597
[TBL] [Abstract][Full Text] [Related]
19. Role of Epac2A/Rap1 signaling in interplay between incretin and sulfonylurea in insulin secretion.
Takahashi H; Shibasaki T; Park JH; Hidaka S; Takahashi T; Ono A; Song DK; Seino S
Diabetes; 2015 Apr; 64(4):1262-72. PubMed ID: 25315008
[TBL] [Abstract][Full Text] [Related]
20. [Structure and action mechanism of sulfonylurea].
Tasaka Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():333-8. PubMed ID: 12387014
[No Abstract] [Full Text] [Related]
[Next] [New Search]
